OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Pioneering first‐in‐class FAAH‐HDAC inhibitors as potential multitarget neuroprotective agents
Alessandro Papa, Ilaria Cursaro, Luca Pozzetti, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 12
Open Access | Times Cited: 7
Alessandro Papa, Ilaria Cursaro, Luca Pozzetti, et al.
Archiv der Pharmazie (2023) Vol. 356, Iss. 12
Open Access | Times Cited: 7
Showing 7 citing articles:
Molecular hybridization: a powerful tool for multitarget drug discovery
Pedro de Sena Murteira Pinheiro, Lucas Silva Franco, Tadeu L. Montagnoli, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 4, pp. 451-470
Closed Access | Times Cited: 40
Pedro de Sena Murteira Pinheiro, Lucas Silva Franco, Tadeu L. Montagnoli, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 4, pp. 451-470
Closed Access | Times Cited: 40
32nd Annual GP2A Medicinal Chemistry Conference
Jean‐Jacques Hélesbeux, Florence O. McCarthy, Maria Manuel Silva, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access
Jean‐Jacques Hélesbeux, Florence O. McCarthy, Maria Manuel Silva, et al.
Drugs and Drug Candidates (2025) Vol. 4, Iss. 1, pp. 2-2
Open Access
A novel potent class I HDAC inhibitor reverses the STAT4/p66Shc apoptotic defect in B cells from chronic lymphocytic leukemia patients
Sara Rossi, Vanessa Tatangelo, Maria Dichiara, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116537-116537
Open Access | Times Cited: 2
Sara Rossi, Vanessa Tatangelo, Maria Dichiara, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 174, pp. 116537-116537
Open Access | Times Cited: 2
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood Malignancies
Gabriele Carullo, Sara Rossi, Valentina Giudice, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 7, pp. 2125-2142
Closed Access | Times Cited: 2
Gabriele Carullo, Sara Rossi, Valentina Giudice, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 7, pp. 2125-2142
Closed Access | Times Cited: 2
Targeting Relevant HDACs to Support the Survival of Cone Photoreceptors in Inherited Retinal Diseases: Identification of a Potent Pharmacological Tool with In Vitro and In Vivo Efficacy
Gabriele Carullo, Noemi Orsini, Ilaria Piano, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 14946-14973
Closed Access | Times Cited: 2
Gabriele Carullo, Noemi Orsini, Ilaria Piano, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 17, pp. 14946-14973
Closed Access | Times Cited: 2
Natural phenol carbamates: Selective BuChE/FAAH dual inhibitors show neuroprotection in an Alzheimer’s disease mouse model
Kuanrong Rong, Ziyun Li, Jinhui Wu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117003-117003
Closed Access | Times Cited: 2
Kuanrong Rong, Ziyun Li, Jinhui Wu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117003-117003
Closed Access | Times Cited: 2
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis Patients
Anna Fontana, Laura Bergantini, Gabriele Carullo, et al.
ACS Pharmacology & Translational Science (2024) Vol. 8, Iss. 2, pp. 380-393
Open Access
Anna Fontana, Laura Bergantini, Gabriele Carullo, et al.
ACS Pharmacology & Translational Science (2024) Vol. 8, Iss. 2, pp. 380-393
Open Access
